Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Hepatitic B Vaccines
Data on hepatitic b vaccines reported by K.N. Szomor and co-researchers
December 31st, 2008
According to a study from Budapest, Hungary, "Hepatitis B virus (HBV) infection has a major effect on health care systems, with about one-third of the world's population currently infected with the virus. There is an effective vaccine against HBV, which contains a recombinant ''surface antigen'' produced in an expression vector." "Vaccination has proved to be successful in Hungary: the number of acute HBV cases has decreased in the past 10 years. Although an increasing number of publications report on ''vaccine-escape'' HBV variants which can infect HBV-vaccinated individuals, such mutant HBV strains have not yet been detected in Hungary. We therefore surveyed two risk...
Source: Vaccine Weekly (2008-12-31)
|
